What they're not telling you: # Planet Fitness's Historic Collapse Exposes The Fitness Industry's Blind Spot Planet Fitness shares plummeted 32 percent in a single trading session—the worst day in the company's recorded history since 2015—after slashing its full-year guidance, yet financial analysts failed to ask executives about the one factor that may explain the membership drought: the explosive adoption of GLP-1 weight-loss drugs like Ozempic and Wegovy. The budget gym chain added more than 700,000 net new members in the first quarter, a figure that would normally signal strength. But Planet Fitness management deemed this performance weak enough to justify cutting 2026 sales growth expectations from 9 percent to 7 percent and slashing adjusted earnings-per-share guidance from a consensus forecast of 9.7 percent to just 4 percent.
What the Documents Show
CEO Colleen Keating attributed the shortfall to "internal and external headwinds," specifically citing severe winter weather in late January and February that disrupted signups, particularly on Mondays—the company's busiest enrollment day. She noted that even the company's historically successful "Black Card first month free" March campaign failed to reignite join momentum as expected, with trends remaining below plan through early April. The company's full-year outlook darkens considerably across every major metric. Club sales growth is now projected at 1 percent instead of 4-5 percent. Revenue guidance dropped to 7 percent growth from 9 percent.
Follow the Money
Adjusted EBITDA expectations fell to 6 percent from 10 percent. Planet Fitness is maintaining its opening guidance of 180-190 new locations, suggesting management believes these are temporary headwinds rather than structural market shifts. Year-to-date, Planet Fitness shares have cratered nearly 60 percent, trading at levels not seen since the depths of the COVID-19 pandemic in 2020, with shares down 61 percent since late 2025. What's striking about this earnings collapse is what Wall Street didn't ask. According to the ZeroHedge source material, not a single analyst questioned whether GLP-1 medication trends—the fastest-growing pharmaceutical category in America—impacted membership. This omission is conspicuous.
What Else We Know
The GLP-1 market has exploded, with millions of Americans now using these weight-loss drugs. If consumers perceive pharmacological solutions as an alternative to gym memberships, that represents an existential threat to the fitness industry that executives and analysts appear unwilling to publicly examine. The Planet Fitness crash signals something ordinary people should recognize: the traditional fitness industry may be facing disruption from an unexpected source. When a company beats earnings estimates but cuts guidance dramatically due to membership weakness, and when the investing class fails to even ask about a seismic shift in consumer health behavior occurring in real time, it suggests the mainstream financial narrative is lagging behind market reality. For gym members and would-be fitness enthusiasts, this serves as a reminder that the fitness industry's foundation—premised on consistent consumer commitment to gym attendance—may be shakier than Wall Street wants to acknowledge.
Primary Sources
- Source: ZeroHedge
- Category: Government Secrets
- Cross-reference independently — don't take our word for it.
Disclosure: NewsAnarchist aggregates from public records, API feeds (Federal Register, CourtListener, MuckRock, Hacker News), and independent media. AI-assisted synthesis. Always verify primary sources linked above.
